Institutional investors purchased a net $18.7 million shares of TEVA during the quarter ended December 2014, and now own 55.34% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 252.7 Thousand shares of Teva Pharmaceutical
CAPFI DELEN ASSET MANAGEMENT SA Bought 149.7 Thousand shares of Teva Pharmaceutical